secwatch.observer — SEC 8-K summary
======================================

Issuer:     FEMASYS INC (FEMY)
CIK:        0001339005
Form:       8-K
Filed at:   2025-08-06T23:59:59+00:00
Accession:  0001140361-25-029065
Event type: other_material
Sentiment:  positive
Materiality: 0.60
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Femasys secures first European order for FemBloc in Spain, approximately $400,000
--------------------------------------------------------------------------------

- First commercial European order for FemBloc permanent birth control valued at ~$400,000 USD.
- Distribution partners in Spain: Comercial Medico Quirúrgica and Durgalab.
- FemBloc is a non-surgical polymer that degrades to form scar tissue for permanent occlusion.
- Company focused on scaling production to meet anticipated European demand.
- Spain is the first country globally to offer FemBloc outside the US.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1339005/000114036125029065/0001140361-25-029065-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1339005/000114036125029065/ef20053293_8k.htm
  HTML page:      https://secwatch.observer/filing/0001140361-25-029065

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer